Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
53.07
-2.00 (-3.63%)
At close: Sep 16, 2025, 4:00 PM EDT
53.00
-0.07 (-0.13%)
Pre-market: Sep 17, 2025, 8:22 AM EDT
Celcuity Market Cap
Celcuity has a market cap or net worth of $2.25 billion as of September 17, 2025. Its market cap has increased by 277.43% in one year.
Market Cap
2.25B
Enterprise Value
2.18B
1-Year Change
277.43%
Ranking
Category
Stock Price
$53.07
Market Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $138.93M to $2.25B, an increase of 1,520.68%. That is a compound annual growth rate of 41.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 2.25B | 363.26% |
| Dec 31, 2024 | 486.03M | 32.18% |
| Dec 29, 2023 | 367.71M | 21.13% |
| Dec 30, 2022 | 303.56M | 54.26% |
| Dec 31, 2021 | 196.78M | 108.63% |
| Dec 31, 2020 | 94.32M | -13.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |